Connection
Steven Bradley to Drug-Eluting Stents
This is a "connection" page, showing publications Steven Bradley has written about Drug-Eluting Stents.
|
|
Connection Strength |
|
|
|
|
|
0.855 |
|
|
|
-
Bittl JA, Baber U, Bradley SM. The Prematurely Stopped Clinical Trial: An Unfinished Symphony. JACC Cardiovasc Interv. 2017 06 26; 10(12):1199-1201.
Score: 0.586
-
Bittl JA, Baber U, Bradley SM, Wijeysundera DN. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016 Sep 06; 134(10):e156-78.
Score: 0.134
-
Bittl JA, Baber U, Bradley SM, Wijeysundera DN. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary?Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 09 06; 68(10):1116-39.
Score: 0.134